| 000 | 01584 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250518063628.0 | ||
| 264 | 0 | _c20200625 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1524-4571 | ||
| 024 | 7 |
_a10.1161/CIRCRESAHA.119.315378 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPang, Li | |
| 245 | 0 | 0 |
_aWorkshop Report: FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant Platforms. _h[electronic resource] |
| 260 |
_bCirculation research _c10 2019 |
||
| 300 |
_a855-867 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCardiotoxicity _xepidemiology |
| 650 | 0 | 4 |
_aCardiotoxins _xtoxicity |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 |
_aEducation _xstandards |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInduced Pluripotent Stem Cells _xdrug effects |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aResearch Report _xstandards |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 650 | 0 | 4 |
_aUnited States Food and Drug Administration _xstandards |
| 700 | 1 | _aSager, Philip | |
| 700 | 1 | _aYang, Xi | |
| 700 | 1 | _aShi, Hong | |
| 700 | 1 | _aSannajust, Frederick | |
| 700 | 1 | _aBrock, Mathew | |
| 700 | 1 | _aWu, Joseph C | |
| 700 | 1 | _aAbi-Gerges, Najah | |
| 700 | 1 | _aLyn-Cook, Beverly | |
| 700 | 1 | _aBerridge, Brian R | |
| 700 | 1 | _aStockbridge, Norman | |
| 773 | 0 |
_tCirculation research _gvol. 125 _gno. 9 _gp. 855-867 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/CIRCRESAHA.119.315378 _zAvailable from publisher's website |
| 999 |
_c30189523 _d30189523 |
||